SG11201506713TA - 2-acylaminothiazole derivative and salt thereof - Google Patents
2-acylaminothiazole derivative and salt thereofInfo
- Publication number
- SG11201506713TA SG11201506713TA SG11201506713TA SG11201506713TA SG11201506713TA SG 11201506713T A SG11201506713T A SG 11201506713TA SG 11201506713T A SG11201506713T A SG 11201506713TA SG 11201506713T A SG11201506713T A SG 11201506713TA SG 11201506713T A SG11201506713T A SG 11201506713TA
- Authority
- SG
- Singapore
- Prior art keywords
- salt
- acylaminothiazole derivative
- acylaminothiazole
- derivative
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013039964 | 2013-02-28 | ||
| PCT/JP2014/054803 WO2014133056A1 (en) | 2013-02-28 | 2014-02-27 | 2-acylaminothiazole derivative and salt thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201506713TA true SG11201506713TA (en) | 2015-09-29 |
Family
ID=51428316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201506713TA SG11201506713TA (en) | 2013-02-28 | 2014-02-27 | 2-acylaminothiazole derivative and salt thereof |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9562044B2 (en) |
| EP (1) | EP2963036B1 (en) |
| JP (1) | JP6183451B2 (en) |
| KR (1) | KR102164821B1 (en) |
| CN (1) | CN105008353B (en) |
| AR (1) | AR094921A1 (en) |
| AU (1) | AU2014221726B2 (en) |
| BR (1) | BR112015020963B1 (en) |
| CA (1) | CA2902302C (en) |
| EA (1) | EA027179B1 (en) |
| ES (1) | ES2748402T3 (en) |
| IL (1) | IL240764A0 (en) |
| MX (1) | MX368539B (en) |
| MY (1) | MY190361A (en) |
| PH (1) | PH12015501899A1 (en) |
| PL (1) | PL2963036T3 (en) |
| PT (1) | PT2963036T (en) |
| SA (1) | SA515360956B1 (en) |
| SG (1) | SG11201506713TA (en) |
| TW (1) | TWI647227B (en) |
| UA (1) | UA118445C2 (en) |
| WO (1) | WO2014133056A1 (en) |
| ZA (1) | ZA201506296B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112016027729B1 (en) * | 2014-05-28 | 2020-11-17 | Astellas Pharma Inc. | compound derived from pyridine, pharmaceutical composition containing said compound and its use |
| HUE043496T2 (en) * | 2014-06-06 | 2019-08-28 | Astellas Pharma Inc | 2-Aminothiazole derivative for use in the prevention or treatment of bladder / urinary tract disorders |
| CN106573928B (en) * | 2014-08-26 | 2020-04-14 | 安斯泰来制药株式会社 | 2-Aminothiazole derivatives or salts thereof |
| PT3228616T (en) * | 2014-12-05 | 2019-11-21 | Astellas Pharma Inc | Pyridine derivatives |
| AR102849A1 (en) * | 2015-03-09 | 2017-03-29 | Astellas Pharma Inc | BICYCLE PIRIDINE COMPOUND |
| TW201713343A (en) * | 2015-04-28 | 2017-04-16 | 安斯泰來製藥股份有限公司 | Pharmaceutical composition for oral administration |
| WO2016183676A1 (en) * | 2015-05-20 | 2016-11-24 | Kent Imaging | Automatic compensation for the light attenuation due to epidermal melanin in skin images |
| CA3099655A1 (en) | 2018-05-08 | 2019-11-14 | Nippon Shinyaku Co., Ltd. | Azabenzimidazole compounds and pharmaceutical |
| RU2709496C1 (en) * | 2019-08-01 | 2019-12-18 | Марат Феликсович Фазылов | Method of producing avatrombopag |
| KR20220100627A (en) | 2019-11-13 | 2022-07-15 | 니뽄 신야쿠 가부시키가이샤 | Azabenzimidazole compounds and medicaments |
| IL298475A (en) * | 2020-06-09 | 2023-01-01 | Anima Biotech Inc | Collagen 1 translation inhibitors and methods of use thereof |
| EP3967311A1 (en) | 2020-09-11 | 2022-03-16 | Astellas Pharma Inc. | Compounds for use in the treatment of dry mouth |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1466912T3 (en) * | 2002-01-18 | 2013-07-01 | Astellas Pharma Inc | 2-ACYLAMINOTHIAZOLD DERIVATIVES OR SALTS THEREOF |
| CN100445281C (en) * | 2003-05-02 | 2008-12-24 | 诺瓦提斯公司 | Quinucidine derivatives that bind to muscarinic M3 receptors |
| AR044134A1 (en) * | 2003-05-02 | 2005-08-24 | Novartis Ag | DERIVATIVES OF QUINUCLIDINE, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS. |
| MXPA06000441A (en) | 2003-07-17 | 2006-04-05 | Astellas Pharma Inc | 2-acylaminothiazole derivative or salt thereof. |
| JP4774995B2 (en) * | 2005-01-12 | 2011-09-21 | アステラス製薬株式会社 | Pharmaceutical composition comprising an acylaminothiazole derivative as an active ingredient |
| JP4665769B2 (en) | 2005-01-12 | 2011-04-06 | アステラス製薬株式会社 | Method for producing acylaminothiazole derivative |
| KR101764952B1 (en) | 2010-07-29 | 2017-08-03 | 리겔 파마슈티칼스, 인크. | Ampk-activating heterocyclic compounds and methods for using the same |
-
2014
- 2014-02-26 TW TW103106494A patent/TWI647227B/en not_active IP Right Cessation
- 2014-02-27 KR KR1020157026269A patent/KR102164821B1/en not_active Expired - Fee Related
- 2014-02-27 SG SG11201506713TA patent/SG11201506713TA/en unknown
- 2014-02-27 EA EA201591391A patent/EA027179B1/en not_active IP Right Cessation
- 2014-02-27 CA CA2902302A patent/CA2902302C/en not_active Expired - Fee Related
- 2014-02-27 MX MX2015011202A patent/MX368539B/en active IP Right Grant
- 2014-02-27 WO PCT/JP2014/054803 patent/WO2014133056A1/en not_active Ceased
- 2014-02-27 PT PT147573778T patent/PT2963036T/en unknown
- 2014-02-27 EP EP14757377.8A patent/EP2963036B1/en active Active
- 2014-02-27 JP JP2015503003A patent/JP6183451B2/en not_active Expired - Fee Related
- 2014-02-27 CN CN201480010396.6A patent/CN105008353B/en not_active Expired - Fee Related
- 2014-02-27 US US14/770,648 patent/US9562044B2/en not_active Expired - Fee Related
- 2014-02-27 ES ES14757377T patent/ES2748402T3/en active Active
- 2014-02-27 UA UAA201508421A patent/UA118445C2/en unknown
- 2014-02-27 AR ARP140100632A patent/AR094921A1/en unknown
- 2014-02-27 BR BR112015020963-7A patent/BR112015020963B1/en not_active IP Right Cessation
- 2014-02-27 MY MYPI2015702844A patent/MY190361A/en unknown
- 2014-02-27 PL PL14757377T patent/PL2963036T3/en unknown
- 2014-02-27 AU AU2014221726A patent/AU2014221726B2/en not_active Ceased
-
2015
- 2015-08-23 IL IL240764A patent/IL240764A0/en active IP Right Grant
- 2015-08-27 ZA ZA2015/06296A patent/ZA201506296B/en unknown
- 2015-08-27 SA SA515360956A patent/SA515360956B1/en unknown
- 2015-08-27 PH PH12015501899A patent/PH12015501899A1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274355B (en) | Aza-pyridone compounds and uses thereof | |
| IL240863B (en) | Amatoxin derivatives | |
| SG11201506100XA (en) | Pyridazinone-amides derivatives | |
| GB2516077B (en) | Decoy | |
| GB201323008D0 (en) | Compounds and uses thereof | |
| SG11201506713TA (en) | 2-acylaminothiazole derivative and salt thereof | |
| ZA201601333B (en) | Oxoquinazolinyl-butanamide derivatives | |
| GB201312318D0 (en) | Novel methods and compounds | |
| IL244214B (en) | Thienopiperidine derivative and use thereof | |
| DK3016978T3 (en) | Humane anti-ifn-alpha-antistoffer | |
| GB201307233D0 (en) | Compounds and uses thereof | |
| SG11201605189YA (en) | Imidazopyrazinone derivatives | |
| DK3016977T3 (en) | Humane anti-il-32-antistoffer | |
| GB201309180D0 (en) | Compounds and Their Uses | |
| GB201314610D0 (en) | Compounds and their uses | |
| GB201306248D0 (en) | Compounds and their uses | |
| IL245452B (en) | Aramchol salt | |
| GB201320161D0 (en) | Compounds and their uses | |
| GB201301393D0 (en) | Kiddibidet and pottibidet | |
| GB201323005D0 (en) | Compounds and uses thereof | |
| GB201304395D0 (en) | Real fit | |
| GB201309248D0 (en) | Compounds and combinations |